Our patient’s clinical manifestations and physical examinations were all consistent with PWS. And his genetic analysis supported this syndrome. Genetic evidence reveals that PWS is caused by functional loss of multiple paternally expressed genes (
6). A gene or genes in the 15q11-13 region must be inherited from each parent for normal human development (
7). If unexplained hypotonia and feeding difficulty appear during the neonatal period, physicians should suspect PWS. Infants who behave the typical craniofacial features of PWS should have genetic testing (
8). The latest information on early diagnosis and management of PWS patients is significant for all physicians and will be useful in anticipating and managing or modifying complications related to this obesity-related disorder (
9).
As our patient’s genetic testing showed, he had compound heterozygous variants of the
ATP8A2 gene. The variants were not reported in any database. Whether he was complicated with other hereditary diseases remains to be discussed. The protein encoded by
ATP8A2 is expressed in all brain regions, with the highest levels in the cerebellum, as well as in retina and testis (
5,
10). The cerebellum is involved in bipedal locomotor activities and is especially important for movement control, balance, and locomotion (
11,
12). Based on the above discussion,
ATP8A2 might be crucial to the development of the central nervous system, and changes in this gene might result in severe neurological phenotypes. CAMRQ4 should be considered in patients who show ataxia, intellectual disability, hypotonia, microcephaly, choreoathetoid movements, ophthalmoplegia, and global developmental delay, even though brain MRI appears normal (
13). Previous literatures described a total of 17 CAMRQ4 patients. Genetic analysis of them showed homozygous or compound heterozygous mutations of the
ATP8A2 gene. Some couples of their parents were first-degree cousins. They all had early-onset, and their first features were hypotonia or developmental delay. In two girls specific time of symptom onset was described (
14). One girl appeared abnormal involuntary movements in extremities and orofacial muscles, and horizontal nystagmus at the age of 2 years. When she was 6 years old, ophthalmoplegia and bilateral optic atrophy were observed. The other girl presented uncontrolled jerky movements, typical of chorea, in her face and four limbs at the age of 8 months. When she was 4.5 years old, she showed ophthalmoplegia and bilateral optic atrophy (
14). Our patient had hypotonia and developmental delay, but these symptoms might be caused by PWS. In many cases, in the clinical course of these disorders when the patients grow older, often additional features appear. Given that our patient is still rather young, further observation is recommended.
Moreover, a c.43delC heterozygous mutation in exon 1 of the
AKAP10 gene was also detected in our patient and his father. This mutation was not reported in any database, either. People with lower vagus nerve sensitivity have faster basal heart rate (HR), less variability of HR (HRV), and higher risk for sudden cardiac death (
15). A single nucleotide polymorphism (SNP) resulting in an amino acid change from Ile to Val at position 646 in the
AKAP10 gene is related to increased basal HR and decreased HRV, which shows that the Val variant has a negative effect on health (
16,
17).
AKAP10 mutant allele has a dominant interfering effect (
16,
18). What’s more, the Val variant has greater atrioventricular node conduction than the Ile variant and is related to an increased risk of myocardial infarction (MI) (
19). Our patient and his father both had normal ECG without clinical features related to heart, showing that the c.43delC heterozygous mutation of
AKAP10 might be susceptible, and the effect of this mutation could appear as they become older. We should take the nonpathogenic possibility into account, so the patient needs further cardiac follow-up.
In conclusion, in patients with dysmorphic facial features, hypotonia, and developmental delay, PWS should be considered in the differential diagnosis. Moreover, other complicated hereditary diseases should be considered in patients with PWS.